Synuclein Gamma Inhibits the Mitotic Checkpoint Function and Promotes Chromosomal Instability of Breast Cancer Cells

Satoru Inaba(VA Palo Alto Health Care System), Jingwen Liu(Second Affiliated Hospital of Zhejiang University), Jian‐Dong Jiang(Ningbo University), Y. Eric Shi(Long Island Jewish Medical Center), Danqing Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Cong Li(Takeda (United States))
Breast Cancer Research and Treatment
September 2, 2005
10.1007/s10549-005-6938-0
Cited by 83

Related Papers

ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
|Metabolism|2008|265
A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy
|Cell Discovery|2021|239
Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation
|Theranostics|2019|185
Loss of Epigenetic Control of <i>Synuclein-γ</i> Gene as a Molecular Indicator of Metastasis in a Wide Range of Human Cancers
|Cancer Research|2005|179